title: Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by Ras-dependent actions of nerve growth factor.
abstract: The extracellular matrix protein agrin plays an important role in the formation and maintenance of the neuromuscular junction. However, regulation of agrin gene expression and pre-mRNA splicing, important in determining the biological actions of agrin, is not well understood. To begin to identify mechanisms controlling agrin expression, quantitative polymerase chain reaction techniques were used to analyze the effect of growth factors on the expression of agrin mRNA isoforms in rat pheochromocytoma (PC12) cells. Agrin transcripts in untreated cells lacked inserts in the Y and Z sites (agriny0z0), encoding agrin isoforms with low acetylcholine receptor aggregating activity and a primarily non-neuronal tissue distribution. Transcripts encoding isoforms with high aggregating activity and neuronal tissue distribution (agriny4z8, agriny4z11, and agriny4z19) were not detected. Treatment of PC12 cells with nerve growth factor (NGF) caused a significant increase in total agrin mRNA. In contrast, exposure to epidermal growth factor had no effect. Analysis of alternative splicing of agrin mRNA revealed that NGF elicited a specific increase in agriny4 and agrinz8 mRNAs that did not occur in the presence of epidermal growth factor, insulin, dexamethasone, or retinoic acid. Analysis of PC12 sublines stably overexpressing a dominant inhibitory form of p21 Ras indicated that NGF induced changes in levels of agrin mRNA and alternative splicing required Ras activity. The results show that NGF can influence important aspects of neuronal differentiation by regulating alternative splicing. Furthermore, these data provide insight into the mechanisms governing agrin gene expression and suggest that neurotrophic factors may play a role in regulating agrin expression in vivo.
authors.affiliation: Department of Anatomy and Neurobiology, University of California at Irvine, Irvine, California 92697, USA. masmith@uci.edu
authors.forename: M A
authors.initials: MA
authors.lastname: Smith
authors.forename: G R
authors.initials: GR
authors.lastname: Fanger
authors.forename: L T
authors.initials: LT
authors.lastname: O'Connor
authors.forename: P
authors.initials: P
authors.lastname: Bridle
authors.forename: R A
authors.initials: RA
authors.lastname: Maue
mesh_terms: D018171:Agrin / Q000235:genetics*; D017398:Alternative Splicing; D000818:Animals; D004815:Epidermal Growth Factor / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D009414:Nerve Growth Factors / Q000378:metabolism*; D016716:PC12 Cells; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D012322:RNA Precursors / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D020917:Receptor, trkA; D017475:Receptors, Nerve Growth Factor / Q000378:metabolism; D018631:ras Proteins / Q000378:metabolism*
chemical_list: D018171:Agrin; D007328:Insulin; D009414:Nerve Growth Factors; D011518:Proto-Oncogene Proteins; D012322:RNA Precursors; D012333:RNA, Messenger; D017475:Receptors, Nerve Growth Factor; D004815:Epidermal Growth Factor; D020794:Receptor Protein-Tyrosine Kinases; D020917:Receptor, trkA; D018631:ras Proteins